Skip to main content
    S

    SeaStar Medical Holding Corporation (ICU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.78
    -0.07 (-8.49%)

    Market Cap: $4.54M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    SeaStar Medical Holding Corporation (ICU) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    SeaStar Medical Holding (ICU) has a market cap of $4.54M and an enterprise value of $548.20K. It kept -678.24% of revenue as net income over the last 12 months. Revenue grew 145.74% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 87.92% below the market cap, as cash exceeds debt.

    Market Cap$4.54M
    Enterprise Value$548.20K
    Latest price (Nov 17, 2026)$0.78

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 7.50% in the quarter ended Sep 30, 2026.

    Shares Outstanding4.39M
    Shares Change (QoQ)+7.50%

    Valuation Ratios

    Sales and book value multiples are 1.6x and 7.3x.

    P/S Ratio1.6x
    Forward P/S2.3x
    P/B Ratio7.3x

    Price Statistics

    The stock is down 79.45% over 52 weeks and trades 72.54% below its 50-day average.

    Beta (1Y)1.36
    52-Week Change-79.45%
    1-Month Change-74.89%
    3-Month Change-76.12%
    6-Month Change-79.92%
    Total Return (1Y)-79.45%
    Total Return (3Y CAGR)-82.15%
    Max Drawdown (1Y)-84.63%
    Max Drawdown (3Y)-99.78%
    Sharpe Ratio (1Y)-1.19
    Correlation with SPY (1Y)0.15
    50-Day Average$2.84
    200-Day Average$3.28
    52-Week Range$0.79 to $5.38
    RSI (14 Days)20.7
    Average Volume (20 Days)290.78K

    Price chart

    Financial Position

    Current assets cover 1.03x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.03x
    Quick Ratio1.02x
    Debt / Equity0.00x
    Interest Coverage-555.30x

    Returns and Efficiency

    Return on equity is -3130.92% and return on assets is -276.53% over the last 12 months.

    Return on Equity (ROE)-3130.92%
    Return on Assets (ROA)-276.53%
    ROIC (5Y Average)503.05%
    Asset Turnover0.21x
    Inventory Turnover2.62x
    Receivables Turnover11.22x
    Cash Conversion Cycle-2357 days

    Scores

    ICU has an Altman Z-Score of -51.56, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-51.56
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $2.17M over the last 12 months.

    Revenue$2.17M
    Revenue Growth (YoY)+145.74%
    Gross Profit$2.00M
    Operating Income-$14.99M
    Pretax Income-$14.68M
    Net Income-$14.68M
    Reported EPS (TTM)-$3.64

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 8.83% of the $5.31M in total assets.

    Cash and Equivalents$3.99M
    Total Debt$0
    Net Cash$3.99M
    Net Cash Per Share$0.91
    Working Capital$126.00K
    Shareholder Equity$469.00K
    Book Value Per Share$0.11
    Total Assets$5.31M
    Total Liabilities$4.84M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$13.22M
    FCF Per Share-$2.49

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -692.52%.

    Gross Margin92.61%
    Operating Margin-692.52%
    Pretax Margin-678.11%
    Net Margin-678.24%

    Dividends and Yields

    ICU does not pay a dividend.

    Buyback Yield-101.11%
    Shareholder Yield-101.11%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jan 5, 2026.

    Last Split DateJan 5, 2026
    Split TypeReverse split
    Split Ratio1:10

    Analyst Forecast

    Consensus estimates put revenue growth at 55.92% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+55.92%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ICU

    What is ICU's market cap?

    SeaStar Medical Holding has a market cap of $4.54M. Its enterprise value, which adds debt and subtracts cash, is $548.20K.

    How many shares of ICU are outstanding?

    SeaStar Medical Holding has 4.39M shares outstanding.

    Does ICU pay a dividend?

    No. SeaStar Medical Holding does not pay a dividend.

    How much debt does ICU have?

    SeaStar Medical Holding has $0 of total debt and $3.99M of cash and equivalents, a net cash position of $3.99M.